KGS

All Exams

Explore All Exams at KGS

All Exams
Current Affairs made simple.

Current Affairs provides you with the best compilation of the Daily Current Affairs taking place across the globe: National, International, Sports, Science and Technology, Banking, Economy, Agreement, Appointments, Ranks, and Report and General Studies

Current Affairs

WHO Issues First-Ever Guidelines for Diagnosis and Management of Type 1 Diabetes in Adults

SYLLABUS

GS-2: Issues relating to development and management of Social Sector/Services relating to Health, Education, Human Resources.

Context: The World Health Organization (WHO) released its first-ever guidelines for diagnosing and managing Type 1 diabetes in adults to improve access to affordable insulin, blood glucose monitoring and quality healthcare.

Key Guidelines for Diagnosing and Managing Type 1 Diabetes in Adults

  • Diagnosis and Classification: Emphasises accurate diagnosis of Type 1 diabetes in adults and distinguishing it from Type 2 diabetes and other forms of diabetes to prevent misdiagnosis and delays in insulin treatment. 

o It recognises that Type 1 diabetes can develop at any age, not just during childhood.

  • Insulin Therapy: Recommends multiple daily insulin injections, with doses adjusted according to blood glucose levels. 

o Human insulin is identified as an appropriate and effective option, while other insulin formulations may be used when required.

  • Blood Glucose Monitoring: Recommends regular monitoring through clinical blood tests measuring average glucose levels over the preceding few months, finger-prick tests or Continuous Glucose Monitoring (CGM) devices using sensors worn on the skin. 

o Urine glucose testing may be considered where blood glucose testing is unavailable.

  • Insulin Delivery and Individualised Management: Addresses appropriate insulin regimens and delivery methods, with treatment adjusted according to individual requirements, blood glucose levels and available healthcare resources.
  • Access to Essential Diabetes Care: Emphasises affordable and uninterrupted access to insulin and glucose-monitoring equipment, particularly in resource-limited settings and during emergencies or humanitarian crises when healthcare services may be disrupted.
  • Implementation and Patient Participation: WHO will provide practical tools and guidance to help countries implement the recommendations and monitor progress. 

o It also encourages involving people with Type 1 diabetes in designing, implementing and evaluating diabetes programmes.

About Diabetes

  • Diabetes mellitus is a chronic metabolic disease characterised by high blood glucose (hyperglycaemia), occurring when the pancreas does not produce enough insulin or the body cannot effectively use the insulin it produces.
  • Types of Diabetes:

o Type 1 Diabetes

o Type 2 Diabetes

o Gestational Diabetes: Hyperglycaemia that develops during pregnancy, with blood glucose levels above normal but below the threshold for diagnosing diabetes.

o Other Specific Types: Include:

  • Monogenic Diabetes: Caused by a single gene defect affecting insulin secretion, such as Maturity-Onset Diabetes of the Young (MODY) and Neonatal Diabetes Mellitus (NDM).
  • Pancreatic Diabetes: Caused by diseases of the pancreas, such as Fibrocalculous Pancreatic Diabetes (FCPD).
  • Mitochondrial Diabetes: A genetic form associated with mitochondrial DNA mutations, often characterised by maternally inherited diabetes and hearing impairment.
  • Other causes: Endocrine disorders, infections, genetic syndromes and certain medications.

About Type 1 Diabetes

  • Type 1 diabetes mellitus (T1DM) is a chronic autoimmune disease in which the immune system destroys insulin-producing beta cells of the pancreas.
  • This results in little or no insulin production, causing elevated blood glucose (hyperglycaemia).
  • People with Type 1 diabetes require lifelong insulin therapy to survive.
  • Causes and Risk Factors:

o Autoimmune response: The immune system mistakenly attacks insulin-producing beta cells.

o Genetic susceptibility: Certain genetic factors, particularly Human Leukocyte Antigen (HLA) genes, increase the risk.

o Environmental factors: Certain viral infections and other environmental factors may contribute to disease development, although the exact causes remain unclear.

  • Symptoms: Common symptoms include increased thirst (polydipsia), frequent urination (polyuria), unexplained weight loss, persistent fatigue and blurred vision.
  • Diagnosis: Diagnosis involves assessing clinical symptoms and measuring blood glucose levels through tests such as Fasting Plasma Glucose (FPG), Oral Glucose Tolerance Test (OGTT) and Glycated Haemoglobin (HbA1c). 

o Diabetes-specific autoantibody tests and C-peptide measurements may help distinguish Type 1 diabetes from other forms of diabetes.

Type 1 Diabetes vs Type 2 Diabetes

Global Burden of Diabetes

  • Around 9.5 million people were living with Type 1 diabetes globally in 2025.
  • Approximately 5 lakh new cases were diagnosed in 2025.
  • In 2022, around 830 million people were living with diabetes worldwide, predominantly Type 2 diabetes.
  • More than 40% of people with diabetes were unaware of their condition and remained undiagnosed.

Related WHO Initiatives

  • Global Diabetes Compact (2021): Launched by WHO to improve diabetes prevention, diagnosis and treatment, particularly in low- and middle-income countries.
  • Global Diabetes Coverage Targets (2022): The World Health Assembly endorsed five global diabetes coverage targets to be achieved by 2030.
  • World Diabetes Day: Observed on 14 November every year to raise awareness about diabetes. The 2026 theme is Early Action on Diabetes.

Khan Global Studies App

The most trusted learning platform on your phone

With our training programs, learning online can be a very exciting experience. Take the next step toward achieving your professional and personal objectives.

Download on the App StoreGet it on Google Play
KGS learning dashboard and mobile application
logo
Khan Global Studies Pvt. Ltd. 5th Floor,
A13A, Graphix 1 Tower B, Sector 62,
Noida, Uttar Pradesh 201309

Course Related Query:

Ask Your DoubtsStore Related Query:[email protected]

Get Free Academic Counseling & Course Details

KGS best learning platform

About Khan Global Studies

We love learning. Through our innovative solutions, we encourage ourselves, our teams, and our Students to grow. We welcome and look for diverse perspectives and opinions because they enhance our decisions. We strive to understand the big picture and how we contribute to the company’s objectives. We approach challenges with optimism and harness the power of teamwork to accomplish our goals. These aren’t just pretty words to post on the office wall. This is who we are. It’s how we work. And it’s how we approach every interaction with each other and our Students.


What Makes Us Different

Come with an open mind, hungry to learn, and you’ll experience unmatched personal and professional growth, a world of different backgrounds and perspectives, and the freedom to be you—every day. We strive to build and sustain diverse teams and foster a culture of belonging. Creating an inclusive environment where every students feels welcome, appreciated, and heard gives us something to feel (really) good about.

©Copyright 2026 KhanGlobalStudies